Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …

Allergen immunotherapy is a cornerstone in the treatment of allergic children. The clinical
efficiency relies on a well‐defined immunologic mechanism promoting regulatory T cells and …

Allergic rhinoconjunctivitis (AR) is an allergic disorder of the nose and eyes affecting about a
fifth of the general population. Symptoms of AR can be controlled with allergen avoidance …

The atopic march recognizes the increased occurrence of asthma, allergic rhinitis, or both
after atopic dermatitis (AD) onset. Mechanisms for develo** atopic comorbidities after AD …

This comprehensive practice parameter for allergic rhinitis (AR) and nonallergic rhinitis
(NAR) provides updated guidance on diagnosis, assessment, selection of monotherapy and …

Allergen immunotherapy (AIT) is a proven therapeutic option for the treatment of allergic
rhinitis and/or asthma. Many guidelines or national practice guidelines have been produced …

Allergic diseases are common and frequently coexist. Allergen immunotherapy (AIT) is a
disease‐modifying treatment for IgE‐mediated allergic disease with effects beyond …

Food allergy (FA) is a potentially life‐threatening chronic condition that is becoming an
increasing public health problem worldwide. This systematic review (SR) was carried out to …

Background Allergy immunotherapy (AIT) is the only treatment for allergic rhinitis (AR)
and/or allergic asthma (AA) with long‐term efficacy. However, there are few real‐life data on …

Background Allergen immunotherapy (AIT) is a disease‐modifying treatment for IgE‐
mediated diseases. Randomized controlled trials (RCTs) support AIT's potential role in …